317 U.S. 519 (1943)
The United States v. American Medical Association is a landmark case in antitrust law that scrutinizes the boundaries of professional organizations' conduct in relation to competition laws.
Does the American Medical Association's conduct to restrict competition against a competitor in the healthcare market violate the Sherman Antitrust Act?
Activities by professional associations that result in an unreasonable restraint on trade or competitive practices violate the Sherman Antitrust Act, even if conducted under the guise of professional regulation and ethics.
The Supreme Court held that the AMA’s actions constituted a conspiracy in restraint of trade in violation of the Sherman Act, affirming the lower court’s decision that the AMA had unlawfully interfered with competitive market dynamics by discouraging its members from engaging with Group Health.
This case matters for law students studying antitrust law because it sets a critical precedent on the application of competition standards to professional and trade associations, not traditionally seen as commercial entities. It underscores the necessity for such associations to align their regulations and practices with broader federal competition principles, ensuring they do not inadvertently or deliberately hinder market competition.